PubMed, Cain, Sean W., et al
It is not intended for long-term blood sugar control
Unlike mild GLP-1 side effects, these symptoms do not resolve with dietary changes and require immediate medical evaluation Core symptoms severe upper abdominal pain pain radiating to the back persistent nausea and vomiting abdominal tenderness fever rapid heart rate Severe warning signs inability to keep fluids down confusion or fainting jaundice breathing difficulty signs of dehydration or shock Pancreatitis is a medical emergency
For broader context on aging biology and metabolic decline research, the NIH National Institute on Aging provides authoritative resources on the metabolic changes and epigenetic mechanisms that underlie age-associated obesity and sarcopenia
Semaglutide is a GLP-1 (glucagon-like-peptide-1) receptor agonist suitable for overweight and obese people who are committed to shedding a significant amount of weight and do not have other significant underlying health issues
Nausea was the most common side effect associated with pramlintide, but it was generally mild to moderate and occurred in less than 10% of participants during the extension phase